Background {#Sec1}
==========

Reliability of brachial blood pressure (BP) measurement in the physician's office has its own limitations, while out-of-office BP measurement, using either home BP monitoring or ambulatory BP monitoring (ABPM) techniques, is devoid of such limitations and is gaining importance in the management of hypertension.

It is now generally accepted that ABPM is an important adjunct to conventional office BP measurement, and ABPM became the "gold standard" for screening, diagnosis, and management of hypertension against the important limitations of office BP which have led to the increasingly frequent suggestion that ABPM \[[@CR1]\]. Among the numerous benefits of ABPM, the avoidance of potential BP measurement errors such as observer bias, terminal digit preference, and provision of more comprehensive information on BP behavior is possible with office or home BP. Ambulatory blood pressure monitors overcome this problem by obtaining multiple readings over the 24-h period and capturing the blood pressure variability \[[@CR2]\].

Current non-invasive strategies for evaluating central aortic BP require recording of a blood vessel weight wave utilizing the MOBIL-O-GRAPH BP device which utilizes brachial BP waves for a non-invasive estimation of central BP \[[@CR3]\]. When brachial artery blood pressure was used to stratify blood pressure measurements, a considerable overlap in aortic systolic pressure was observed, such that over 70% of individuals were categorized as having "high-normal" brachial systolic pressure based on Joint European Cardiology and Hypertension Society guidelines \[[@CR4]\], and the authors postulated that we may be treating some patients with relatively low central pressures and not treating individuals with elevated central pressures, because they have brachial systolic pressures under current treatment thresholds. McEniery et al. \[[@CR5]\] suggested that NICBP will have important clinical implications if central pressure turns out to be a better predictor of cardiovascular risk, because it suggests that. The Dicomano Study in Italy \[[@CR6]\] and a Taiwanese study \[[@CR7]\] also observed a stronger association between cardiovascular events and central, rather than brachial pressure. The heart, kidneys, and major arteries supplying the brain are exposed to aortic rather than brachial pressure. Therefore, there is a strong rationale to believe that cardiovascular events may ultimately be more closely related to central rather than brachial pressure. Evidence published over the last 12 years is concerning the relationship between central pressures \[[@CR8]\].

Methods {#Sec2}
=======

The study group included 100 hypertensive patients recruited from the hypertension clinic in Assiut University Hospital, during the period from June 2016 to July 2017. Patients were divided into two groups, either controlled or uncontrolled office BP according to the European Society of Cardiology (ESC) guidelines 2013 (≥ 140 mmHg systolic BP (SBP) and/or ≥ 90 mmHg diastolic BP (DBP).

A detailed history was obtained, and complete clinical examination was performed including patients' weight and height to calculate body mass index (BMI).

Office pressure blood pressure measurement was done according to ESC 2013; we measured the systolic and diastolic blood pressure and compared the results with those of ABPM and NICBP.

For measurements of ABPM, we used NICE recommendations to ensure that at least two measurements per hour are taken during the person's usual waking hours. We used the average value of at least 14 measurements taken during the person\'s usual waking hours to confirm a diagnosis of hypertension. The device was programmed to obtain BP readings at 30-min interval during the day (08:00--22:00 h) and at 60-min intervals during the night (22:00--08:00 h) \[[@CR9]\]. We measured systolic and diastolic blood pressure and compared the results with those of office BP and NICBP.

Blood pressure varies over 24 h with a number of well-recognized patterns. Dippers are individuals characterized by at least a 10% decline in nocturnal BP compared to their awake BP \[[@CR10]\]. Most of the patients are dippers. Non-dippers are individuals having blunted or absent blood pressures which decline during sleep \[[@CR11]\]. Approximately 10--30% of patients are "non-dippers," and in our study, non-dippers represent 34% of our patients.

We obtained the central blood pressure curve of our patients in a quiet, temperature-controlled examination room at the hypertension clinic. Three measurements were taken with a 2-min break between them by using Mobilograph device. The procedure was performed with the patient in a supine position and using an adequately sized cuff (the Mobil-O-Graph 24 h PWA ABPM device (IEM, Stolberg, Germany) \[[@CR12], [@CR13]\]).

We measured systolic and diastolic blood pressures and compared them with the measurements of both office and ABPM.

We measured pulse wave velocity (m/s) (PWV) by Mobilograph and compared the result and age to detect the degree of arterial thickness related to hypertension. The slower the pulse wave velocity is, the better the heart health is. However, normal pulse wave velocity values vary according to age. We measured also the mean arterial pressure (MAP) and augmentation index (AI).

Blood samples were collected to measure serum creatinine and to exclude patients with a glomerular filtration rate of \< 30 ml/min/1.73 m^2^. The measurement of GFR was obtained by the Cockcroft-Gault formula study equation.

ECG was used to measure the left ventricular hypertrophy (LVH) using "Sokolow-Lyon ≥ 38 mm \[[@CR14]\]. Echocardiography using Phillips IE33 ultrasound system was performed to all patients in addition to controls. Images were obtained from the short-axis view and longitudinal parasternal 4-chamber, 2-chamber, and 5-chamber slices. LV mass (LVM) and LVMI were calculate using LVMI = LV mass/BSA calculated by the Mosteller formula \[[@CR15]\]. Ejection fraction (EF %) was calculated using Simpson's method \[[@CR16]\].

Carotid intimal medial thickness (CIMT) was measured with Doppler ultrasound (US) on the carotid artery to detect increased thickness related to hypertension. The intima-media complex can easily be distinguished from the surrounding tissue in US images, and the distinct borders allow for manual as well as automatic measurements of the CIMT. Damage is defined as the presence of CIMT \> 0.9 mm or plaque \[[@CR17]\].

ABI was calculated by measuring the systolic blood pressure from both brachial arteries and from both the dorsalis pedis and posterior tibial arteries at rest in the supine position. The systolic pressures were recorded with a handheld 5- or 10-mHz Doppler instrument \[[@CR18], [@CR19]\]. Normal ABI ranges from 1.0 to 1.4; values above 1.4 suggest a non-compressible calcified vessel. However, a value below 0.9 is considered diagnostic of peripheral arterial disease (PAD).

Statistical analysis {#Sec3}
====================

The data were tested for normality using the Anderson-Darling test and for homogeneity variances prior to the further statistical analysis. Categorical variables were described by the number and percent (*N*, %), where continuous variables are described by mean and standard deviation (mean, SD). The chi-square test and Fisher exact test were used to compare categorical variables where comparisons between continuous variables were done by *t* test and independent samples *t* test ANOVA. A two-tailed *p* \< 0.05 was considered statistically significant. We used the Pearson and Spearman correlation to determine the association between variables. All analyses were performed with the IBM SPSS 20.0 software. The receiver operating characteristic (ROC) curve was done for the most powerful predictors for determination of cutoff point to be a risk factor for end organ damage. Post hoc tests are run to confirm where the differences occurred between groups; they should only be run when you have a shown an overall statistically significant difference in group means (i.e., a statistically significant one-way ANOVA result).

Results {#Sec4}
=======

The demographic and clinical characteristics of the study population are presented in Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}, (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). Table 1Characteristics of the controlled versus uncontrolled groups with office blood pressure measurementVariableControlled, *N* = 50Uncontrolled, *N* = 50*P*All, *N* = 100Male12 (24%)15 (30%)0.49927 (27%)Female38 (76%)35 (70%)73 (73%)Age48.1 ± 7.7546.94 ± 8.960.49047.52 ± 8.35BMI32.7 ± 5.631 ± 5.220.11931.85 ± 5.45Smoking12 (24%)13 (26%)0.81725 (25%)Duration of HTN6.78 ± 4.476.1 ± 3.730.4116.44 ± 4.11F. history28 (56%)27 (54%)0.84155 (55%)Office systolic135.12 ± 19.45143.56 ± 29.40.087138.58 ± 24.25Office diastolic88.53 ± 16.6585.37 ± 15.040.34187.33 ± 16.05ABPM systolic125.15 ± 17.93128.96 ± 25.90.395126.05 ± 20.42ABPM diastolic87.63 ± 18.5286.04 ± 12.470.61686.84 ± 15.99Night Dipper36 (72%)30 (60%)0.20566 (66%) Not dipper14 (28%)20 (40%)34 (34%)Central systolic126.07 ± 19.41130.63 ± 27.610.348127.44 ± 22.14Central diastolic89.49 ± 17.9388.77 ± 13.890.83189.21 ± 16.40PWV7.25 ± 1.097.8 ± 1.330.024\*7.52 ± 1.24Augmentation index24.3 ± 9.7125.84 ± 11.750.47725.07 ± 10.75MAP102.42 ± 16.2798.88 ± 14.530.254100.65 ± 15.45Cr0.8 ± 0.311.04 ± 0.340.000\*\*0.92 ± 0.35GFR118.04 ± 48.2994.88 ± 51.170.022\*106.46 ± 50.85LVMI0.92 ± 0.120.95 ± 0.130.3110.93 ± 0.13EF59.34% ± 5.69%59.12% ± 5.83%0.84959.23% ± 5.73%CIMT0.7 ± 0.120.77 ± 0.140.008\*\*0.74 ± 0.13ABI0.91 ± 0.20.95 ± 0.270.3220.93 ± 0.24*BMI* body mass index, *HTN* hypertension, ABPM ambulatory blood pressure monitoring, *PWV* pulse wave velocity, *MAP* mean arterial pressure, *Cr* creatinine, *GFR* glomerular filtration ratio, *LVMI* left ventricular mass index, *EF* ejection fraction, *CIMT* carotid intimal thickness, *ABI* ankle brachial index\* Statistically significant difference (*p* \< 0.05), \*\*highly statistically significant difference (*p* \< 0.01) Table 2Blood pressure variabilityABPM SBP "controlled"Central SBP "controlled"*P*SBP57 (57%)70 (70%)0.056DBP56 (56%)61 (61%)0.473Mean BP57 (57%)67 (67%)0.419Post hoc (LSD test), P: Comparison between ABPM SBP and central SBP*HTN* hypertension, *ABPM* ambulatory blood pressure monitoring, *PWV* pulse wave velocity, *Cr* creatinine, *GFR* glomerular filtration ratio, *LVMI* left ventricular mass index, *CIMT* carotid intimal medial thickness, *ABI* ankle-brachial index\*Statistically significant difference (*p* \< 0.05)\*\*Highly statistically significant difference Table 3Relation between SBP measured by different tools monitoring and early hypertensive end organ damageABPM*P* valueCentral*P* valueControlledNot controlledControlledNot controlledNo. (%)No. (%)No. (%)No. (%)ECG Normal48 (96%)13 (26%)0.000\*\*49 (90.7%)12 (26.1%)0.000\*\* LVH2 (4%)34 (68%)5 (9.3%)31 (67.4%) LBBB0 (0%)3 (6%)0 (0%)3 (6.5%)LVMI Normal47 (94%)37 (74%)0.006\*\*52 (96.3%)32 (69.6%)0.000\*\* Abnormal3 (6%)13 (26%)2 (3.7%)14 (30.4%)CIMT Normal47 (94%)37 (74%)0.006\*\*51 (94. 4%)33 (71.7%)0.002\*\* Abnormal3 (6%)13 (26%)3 (5. 6%)13 (28.3%)PWV Normal50 (100%)43 (86%)0.006\*\*54 (100%)39 (84.8%)0.003\*\* Abnormal0 (0%)7 (14%)0 (0%)7 (15. 2%)ABI Normal39 (78%)21 (42%)0.000\*\*41 (75.9%)19 (41.3%)0.000\*\* Abnormal11 (22%)29 (58%)13 (24.1%)27 (58.7%)Creatinine Normal47 (94%)30 (60%)0.000\*\*52 (96.3%)25 (54.3%)0.000\*\* Abnormal3 (6%)20 (40%)2 (3.7%)21 (45.7%)GFR Normal47 (94%)36 (72%)0.003\*\*50 (92.6%)33 (71.7%)0.006\*\* Abnormal3 (6%)14 (28%)4 (7.4%)13 (28.3%)Chi-square test\*Statistically significant difference (*p* \< 0.05)\*\*Highly statistically significant difference (*p* \< 0.01)*HTN* hypertension, *ABPM* ambulatory blood pressure monitoring, *PWV* pulse wave velocity, *Cr* creatinine, *GFR* glomerular filtration ratio, *LVMI* left ventricular mass index, *CIMT* carotid intimal thickness, *ABI* ankle-brachial index Table 4The correlation between each blood pressure monitoring and hypertensive end organ damage parametersLVMICIMTPWVABICrGFRECGABPM SBP*R*0.3260.3850.3360.4390.473− 0.2650.793*P*\< 0.001\*\*\< 0.001\*\*\< 0.001\*\*\< 0.001\*\*\< 0.001\*\*0.008\*\< 0.001\*\*ABPM DBP*R*0.2860.3170.2140.4180.325− 0.1810.656*P*0.004\*\*\< 0.001\*\*0.032\< 0.001\*\*\< 0.001\*\*0.072\< 0.001\*\*Central SBP*R*0.3470.3300.3690.4370.439− 0.2540.720*P*\< 0.001\*\*\< 0.001\*\*\<0.001\*\*\< 0.001\*\*\< 0.001\*\*0.011\*\< 0.001\*\*Central DBP*R*0.1110.1180.2090.1560.1330.0460.506*P*0.2710.2430.037\*0.1200.1860.651\< 0.001\*\**R* value is the correlation coefficient r measures the strength and direction of a linear relationship between two variables on a scatterplot. The value of r is always between + 1 and − 1*SBP* systolic blood pressure, *DBP* diastolic blood pressure, *HTN* hypertension, *ABPM* ambulatory blood pressure monitoring, *PWV* pulse wave velocity, *Cr* creatinine, *GFR* glomerular filtration ratio, *LVMI* left ventricular mass index, *CIMT* carotid intimal thickness, *ABI* ankle-brachial index\*Statistically significant difference (*p* \< 0.05)\*\*Highly statistically significant difference (*p* \< 0.01) Table 5Logistic regression models for hypertensive end organ damageECGLVMIOdds ratioConfidence interval*P* valueOdds ratioConfidence interval*P* valueAMBP SBP (uncontrolled/controlled)0.0810.029--0.224*0.000\*\**0.2000.065--0.617*0.005\*\**AMBP MAP (uncontrolled/controlled)0.1010.030--0.334*0.000\*\**0.1670.053--0.529*0.002\*\**Central SBP (uncontrolled/controlled)0.6700.271--1.656*0.386*0.3760.124--1.143*0.085*Central MAP (uncontrolled/controlled)0.2860.117--0.697*0.006\*\**0.3550.119--1.060*0.063*CIMTPWVOdds ratioConfidence interval*P* valueOdds ratioConfidence interval*P* valueAMBP SBP (uncontrolled/controlled)0.5140.172--1.538*0.234*0.0610.007--0.535*0.012\**AMBP MAP (uncontrolled/controlled)0.7060.201--2.478*0.587*0.2980.061--1.458*0.135*Central SBP (uncontrolled/controlled)0.0590.006--0.524*0.014\**0.0650.008--0.564*0.010\**Central MAP (uncontrolled/controlled)0.3550.119--1.060*0.063*0.0750.010--0.602*0.014\**ABICrGFROdds ratioConfidence interval*P* valueOdds ratioConfidence interval*P* valueOdds ratioConfidence interval*P* value0.1440.056--0.371*0.000\*\**0.3830.146--1.003*0.051*0.4870.171--1.388*0.178*0.2060.071--0.598*0.004\*\**0.2590.090--0.743*0.012\**0.4120.142--1.283*0.126*0.7100.288--1.752*0.457*1.3500.445--4.098*0.596*0.4740.161--1.392*0.174*0.5560.234--1.322*0.184*2.1920.832--5.778*0.112*1.1400.367--3.543*0.820*Logistic regression included the following independent variables: central SBP: uncontrolled = 1/controlled = 2; central MAP: abnormal = 1/normal = 2; ABPM SBP: uncontrolled = 1/controlled = 2; ABPM MAP: uncontrolled = 1/controlled = 2. Values in italics represent significant *P* value \< 0.05*ABPM* ambulatory blood pressure monitoring, *PWV* pulse wave velocity, *Cr* creatinine, *GFR* glomerular filtration ratio, *LVMI* left ventricular mass index, *CIMT* carotid intimal thickness, ABI ankle-brachial index\*Statistically significant difference (*p* \< 0.05)\*\*Highly statistically significant difference (*p* \< 0.01) Fig. 1High sensitivity of ABPM DBP with CIMT (92.9%) Fig. 2High sensitivity of ABPM SBP with ABI (98.2%) Fig. 3High specificity of central SBP with PWV (97.6%) Fig. 4High sensitivity of central DBP with ABI (90.3%)

Discussion {#Sec5}
==========

In our study, we found that 24 h ABPM and non-invasive central BP monitoring are good predictable measures for early detection of hypertensive end organ damage.

In accordance with our results, Hansen et al. compare between 24 h ABPM and office BP. ABPM and office BP were entered in the same multivariate models, only the ABPM was a significant predictor of all-cause mortality and cardiovascular mortality; however, the relative risks of cardiovascular mortality were lower for office blood pressure, and office blood pressure did not predict all-cause mortality \[[@CR20]\]. Wang et al. showed that central BP is more valuable than other blood pressure variables in predicting cardiovascular mortality \[[@CR7]\].

After the analysis of our data, we found that all tools of BP measurements (Office --ABPM -- Central) are correlated significantly with ECG changes (LVH or LBBB). ABPM SBP and DBP parameters are significantly correlated with ECG changes caused by hypertension. Central SBP, DBP, and PWV parameters are significantly correlated with ECG changes caused by hypertension.

We found that 24 h APBM and central BP are strong predictors for increasing in LVM as assessed by echocardiography. de Luca et al. showed the superiority of central SBP over brachial SBP as a major determinant of LVM regression which has recently been shown in 52 hypertensive patients treated with low-dose perindopril/indapamide and atenolol \[[@CR21]\].

Central BP is more closely correlated with widely accepted surrogate measures of cardiovascular risk such as LVMI; a closer association of central pressure with LVMI was also found in the population-based Strong Heart Study \[[@CR22]\] in which central systolic BP was more strongly associated with LVH determined by echocardiography. ABPM SBP and DBP parameters are significantly correlated with LVMI changes caused by hypertension. Central SBP and PWV parameters are significantly correlated with LVMI changes caused by hypertension.

Central BP and 24 h ABPM are significantly related to the changes in CIMT which are caused by hypertension. Mancia et al. had found that the end organ damage was determined not only by the degree of the high BP level but also by the 24 h ABPM. In our study, we found that both ABPM and central BP are also good predictors for CIMT changes but office BP is not conclusive for hypertensive CIMT changes. ABPM SBP and DBP parameters are significantly correlated with CIMT changes caused by hypertension. Central SBP and PWV parameters are significantly correlated with CIMT changes caused by hypertension.

PWV is an important marker for cardiovascular changes, and in our study, we find that both ABPM and central BP are significantly related to PWV with some superiority to central BP. In accordance with our results, Spronck et al. stated that office and out-of-office BP are independent predictors of aortic PWV in hypertension.

Elevated BP values over the 24 h are associated with increased aortic stiffness, so ABPM is a good predictor \[[@CR23]\]. ABPM SBP and DBP parameters are significantly correlated with PWV changes caused by hypertension. Central SBP parameter is significantly correlated with PWV changes caused by hypertension.

In our study, we found that both 24 h ABPM and central BP are more predictable than office BP; however, Wittke et al. showed that the variability of systolic blood pressure over time derived from ABPM is associated with the ankle-brachial index \[[@CR24]\]. ABPM SBP and DBP parameters are significantly correlated with ABI changes caused by hypertension. Central SBP, DBP, and PWV parameters are significantly correlated with ABI changes caused by hypertension.

Both ABPM and Central BP are correlated with changes in Cr level and GFR caused by hypertension in our study. However, this point is controversial with many studies, such as the Framingham Heart Study, which failed to identify an association between central BP and renal function \[[@CR25]\] while Karras et al. \[[@CR26]\] demonstrated that central hemodynamic and arterial stiffness parameters are associated with renal impairment. ABPM SBP and DBP parameters are significantly correlated with Cr level changes caused by hypertension. Central SBP, DBP, and PWV parameters are significantly correlated with Cr level changes caused by hypertension.

Conclusion {#Sec6}
==========

AMBP and NCBP show a significant relation to LVMI, CIMT, PWV, and GFR with little superiority of central BP while office BP does not. Systolic AMBP has high sensitivity to ABI and CIMT and systolic NCBP has a high sensitivity and specificity to ABI.
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Study limitations {#FPar2}
=================

The difference in time of measuring ABPM was done over 24 h while central blood pressure monitoring during only 30 minInvestigations were done over a period of several days which was an obstacle for some patients to continue in the study. These patients had to be excludedUnawareness of the serious complications of hypertension for many patientsThe small number of patient population
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